Medical Isotope Production Market Revenue to Attain USD 8.95 Bn by 2033


14 Jul 2025

Share : linkedin twitter facebook

The global medical isotope production market revenue surpass USD 4.71 billion in 2025 and is predicted to attain around USD 8.95 billion by 2033, growing at a CAGR of 8.34%. The market is attributed to the surging global demand for radioactive isotopes, driven by the increasing prevalence of cancer, cardiovascular diseases, and neurological diseases.

Medical Isotope Production Market Revenue Statistics

What are the Key Factors Driving the Growth of the Medical Isotope Production Market?

The global market for medical isotope production is expanding rapidly due to several key factors. One of the major factors is the increasing demand for medical diagnostic imaging procedures, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), due to the rise in the number of cases of cancer and cardiovascular diseases. Ongoing advances in nuclear medicine and diagnostic imaging are improving the accuracy and efficiency of isotope-based diagnostic tests. The increasing use of radiopharmaceuticals also drives the market's growth.

Expanding healthcare infrastructure, rising healthcare expenditure, and increasing R&D in radiopharmaceuticals create immense opportunities in the market. There is expanding access to nuclear medicine, which is likely to propel the growth of the market. Moreover, government support aimed at boosting domestic isotope production contributes to the growth of the market. There is a significant push toward creating non-reactor (e.g., cyclotron)-based alternatives that may produce isotopes in a safer and sustainable way, which is expected to fuel market growth.

Segment Outlook

  • By isotope type, the diagnostic isotopes segment dominated the market in 2024. This is primarily due to the increased demand and supply of isotopes, such as Technetium-99m, which are frequently used in the development of new and advanced diagnostic imaging methodologies, including nuclear medicine imaging.
  • By production technology, the nuclear reactor-based production segment led the market with a major revenue share in 2024. This is mainly due to its low-cost and large quantity production capabilities, which are beneficial particularly for commonly used isotopes (such as Molybdenum-99) used in diagnostic imaging.
  • By application, the diagnostic segment dominated the market in 2024 due to the increased demand for nuclear imaging in the fields of oncology, cardiology, and neurology. There is a high usage of medical isotopes like Technetium-99m (Tc-99m) in SPECT and PET scans for diagnosing various diseases, supporting segmental growth.
  • By end-user, the hospitals & clinics segment led the market in 2024, as they are primary end-users of medical imaging isotopes. These settings increasingly use nuclear imaging technologies to detect illness and prescribe treatment in a timely manner. The growing focus on a patient-centric care approach further supports segmental growth.

Regional Insights

North America dominated the medical isotope production market in 2024 due to its well-established healthcare systems, increased demand for advanced diagnostic imaging, such as SPECT and PET, the presence of major industry players, and ongoing innovations in nuclear medicine. There is a high prevalence of chronic diseases, supporting market growth. Moreover, the rising development of new isotopes contributes to market expansion.

Meanwhile, Asia Pacific is expected to experience the fastest growth in the upcoming period, driven by rising healthcare expenditure, growing acceptance of nuclear imaging procedures, and government initiatives to improve domestic production of isotopes. Moreover, the rising demand for radiopharmaceuticals drives the growth of the market within the region.

Medical Isotope Production Market Coverage

Report Attribute Key Statistics
Market Revenue in 2025 USD 4.71 Billion
Market Revenue by 2033 USD 8.95 Billion
CAGR from 2025 to 2033 8.34%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2024
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Recent Development

  • In June 2025, the Department of Energy Isotope Program (DOE IP) increased the availability of popular theranostic isotopes, such as terbium-155, rhenium-186, and tin-117m, through upgrades to facilities.
    (Source- https://isotopes.gov)

Medical Isotope Production Market Key Players

  • Curium Pharma
  • BWX Technologies, Inc.
  • Nordion (Canada) Inc. – a Sotera Health company
  • Cardinal Health
  • NTP Radioisotopes (South Africa)
  • SHINE Technologies
  • NorthStar Medical Radioisotopes, LLC
  • Rosatom State Atomic Energy Corporation (Isotope JSC)
  • Isotopia Molecular Imaging Ltd.
  • Institute of Radioelements (IRE)
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Lantheus Holdings, Inc.
  • Siemens Healthineers (PETNET Solutions)
  • Advanced Accelerator Applications (a Novartis company)
  • Center for Probe Development and Commercialization (CPDC)
  • Australian Nuclear Science and Technology Organisation (ANSTO)
  • ITM Isotopen Technologien München AG
  • IBA Radiopharma Solutions
  • Cyclotron Products Inc
  • GE Healthcare

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6385

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344

Related Reports